Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB Pancreatic Cancer”

167 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 167 results

Early research (Phase 1)Study completedNCT00033241
What this trial is testing

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
OSI Pharmaceuticals
Early research (Phase 1)Ended earlyNCT06130254
What this trial is testing

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Who this might be right for
Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Early research (Phase 1)Active Not RecruitingNCT03889795
What this trial is testing

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

Who this might be right for
Advanced Pancreatic CancerAdvanced Solid Tumor
Danae Hamouda, MD 15
Early research (Phase 1)UnknownNCT02975141
What this trial is testing

Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
PD Dr. med. Volker Heinemann 12
Testing effectiveness (Phase 2)WithdrawnNCT03697239
What this trial is testing

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Hitendra Patel
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)Study completedNCT03269526
What this trial is testing

BATs Treatment for Pancreatic Cancer, Phase Ib/II

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
University of Virginia 22
Early research (Phase 1)Study completedNCT00955773
What this trial is testing

The GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

Who this might be right for
Cancer
GlaxoSmithKline 64
Testing effectiveness (Phase 2)Looking for participantsNCT07692750
What this trial is testing

IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Zhejiang Cancer Hospital 56
Early research (Phase 1)Not Yet RecruitingNCT07555587
What this trial is testing

Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)

Who this might be right for
Unresectable Locally Advanced Pancreatic Carcinoma
NRT MedTech Australia Pty Ltd 10
Early research (Phase 1)Study completedNCT01473940
What this trial is testing

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
Northwestern University 21
Testing effectiveness (Phase 2)Study completedNCT00288925
What this trial is testing

Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment

Who this might be right for
Pancreatic Cancer
Zeria Pharmaceutical 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678593
What this trial is testing

GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation

Who this might be right for
Advanced Solid Tumors CancerPancreatic Ductal AdenocarcinomaRAS Mutation
Genfleet Therapeutics (Shanghai) Inc. 222
Not applicableEnded earlyNCT04400903
What this trial is testing

Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8Stage IA Pancreatic Cancer AJCC v8+1 more
OHSU Knight Cancer Institute 110
Testing effectiveness (Phase 2)Study completedNCT02807844
What this trial is testing

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 141
Testing effectiveness (Phase 2)Ended earlyNCT04643405
What this trial is testing

APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic Cancer
Ascentage Pharma Group Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT02331251
What this trial is testing

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Who this might be right for
Advanced CancerBreast CancerSarcoma+3 more
Western Regional Medical Center 81
Testing effectiveness (Phase 2)Looking for participantsNCT07433283
What this trial is testing

Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

Who this might be right for
Tumor, SolidLung CancerPancreas Cancer+4 more
Sichuan Enray Pharmaceutical Sciences Company 54
Next Page